Adalimumab/golimumab/infliximabCytomegalovirus infection, development of anti-drug antibodies and lack of efficacy: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1885卷 / 1期
关键词：
D O I：
10.1007/s40278-021-06787-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：28 / 28
相关论文
共 50 条
  • [41] Adalimumab/minocyclineCutaneous leishmaniasis and lack of efficacy: case report
    Reactions Weekly, 2022, 1896 (1) : 23 - 23
  • [42] Adalimumab/mesalazineParadoxical psoriasis and lack of efficacy: case report
    Reactions Weekly, 2025, 2050 (1) : 23 - 23
  • [43] Adalimumab/rifampicinLeukocytoclastic vasculitis and lack of efficacy: case report
    Reactions Weekly, 2021, 1873 (1) : 20 - 20
  • [44] Adalimumab/methotrexateCytomegalovirus oesophagitis and lack of efficacy: case report
    Reactions Weekly, 2023, 1969 (1) : 24 - 24
  • [45] Detection of infliximab, adalimumab, and anti-drug antibodies: Development and validation of new monotest, automated assays on multiparametric instrument
    Cerutti, Helena
    Tesi, Giulia
    Petrini, Francesco
    Bandini, Tommaso
    Cartocci, Alessandra
    Ianniello, Andrea
    Bogi, Alessia
    Muzzi, Chiara
    Brogi, Alessandra
    PRACTICAL LABORATORY MEDICINE, 2024, 39
  • [46] Therapeutic Drug Monitoring of the Biosimilar (AMJEVITA™, Adalimumab-atto) Using Labcorp Adalimumab Assay for Drug Level and Anti-Drug Antibodies
    Chun, Kelly Y.
    Bastidas, Monique
    Yeo, Lythou
    Magpantay, Susie
    Scott, Judah
    Zikry, Michael
    Galdamez, Wayne
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S5 - S6
  • [47] Alemtuzumab depletion failure and neutralizing anti-drug antibodies: a case report and call for monitoring
    Munger, K.
    Kang, A.
    Baker, D.
    Goodman, A.
    Samkoff, L.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 258 - 258
  • [48] Alemtuzumab Depletion Failure and Neutralizing Anti-Drug Antibodies: a Case Report and Call for Monitoring
    Munger, Kathleen
    Kang, Angray
    Baker, David
    Goodman, Andrew
    Samkoff, Lawrence
    NEUROLOGY, 2020, 94 (15)
  • [49] Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
    Gorovits, B.
    Baltrukonis, D. J.
    Bhattacharya, I
    Birchler, M. A.
    Finco, D.
    Sikkema, D.
    Vincent, M. S.
    Lula, S.
    Marshall, L.
    Hickling, T. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03): : 348 - 365
  • [50] Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial
    Marona, Jose
    Rodrigues-Manica, Santiago
    Gomes, Joao Lagoas
    Lopes, Carina
    Iria, Ines
    Bernardes, Miguel
    Santos, Helena
    Tavares-Costa, Jose
    Madruga-Dias, Joao
    Pinto, Patricia
    Bernardo, Alexandra
    Maia, Sara
    Branco, Jaime
    Goncalves, Joao
    Pimentel-Santos, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345